Luye Pharma Group Ltd. (2186.HK)
HKD 2.17
(-2.25%)
HKD 2.17
(-2.25%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 8.42 Billion CNY | -7.48% |
| 2022 | 9.1 Billion CNY | -4.07% |
| 2021 | 9.49 Billion CNY | -4.92% |
| 2020 | 9.98 Billion CNY | 23.75% |
| 2019 | 8.06 Billion CNY | 31.41% |
| 2018 | 6.13 Billion CNY | 114.52% |
| 2017 | 2.86 Billion CNY | 76.18% |
| 2016 | 1.62 Billion CNY | 223.07% |
| 2015 | 502.71 Million CNY | 64.53% |
| 2014 | 305.53 Million CNY | -59.01% |
| 2013 | 745.3 Million CNY | 0.0% |
| 2012 | - CNY | -100.0% |
| 2011 | 455.81 Million CNY | 71.71% |
| 2010 | 265.45 Million CNY | 32.27% |
| 2009 | 200.68 Million CNY | 42.56% |
| 2008 | 140.77 Million CNY | -44.37% |
| 2007 | 253.05 Million CNY | 774.64% |
| 2006 | 28.93 Million CNY | 169.39% |
| 2005 | 10.74 Million CNY | -81.16% |
| 2004 | 57 Million CNY | -54.4% |
| 2003 | 125.01 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 9.38 Billion CNY | 11.41% |
| 2024 Q2 | 9.38 Billion CNY | 0.72% |
| 2023 Q3 | 8.4 Billion CNY | -14.81% |
| 2023 Q2 | 9.86 Billion CNY | 0.13% |
| 2023 Q1 | 9.85 Billion CNY | 8.24% |
| 2023 FY | 8.42 Billion CNY | -7.48% |
| 2023 Q4 | 8.42 Billion CNY | 0.22% |
| 2022 Q3 | 9.08 Billion CNY | -1.06% |
| 2022 Q2 | 9.18 Billion CNY | 0.17% |
| 2022 Q1 | 9.17 Billion CNY | -3.37% |
| 2022 FY | 9.1 Billion CNY | -4.07% |
| 2022 Q4 | 9.1 Billion CNY | 0.17% |
| 2021 Q3 | 9.46 Billion CNY | 6.3% |
| 2021 Q4 | 9.49 Billion CNY | 0.24% |
| 2021 Q1 | 8.89 Billion CNY | -10.86% |
| 2021 Q2 | 8.9 Billion CNY | 0.1% |
| 2021 FY | 9.49 Billion CNY | -4.92% |
| 2020 Q4 | 9.98 Billion CNY | 0.13% |
| 2020 Q1 | 8.97 Billion CNY | 11.27% |
| 2020 FY | 9.98 Billion CNY | 23.75% |
| 2020 Q3 | 9.96 Billion CNY | 10.89% |
| 2020 Q2 | 8.98 Billion CNY | 0.16% |
| 2019 Q3 | 8.53 Billion CNY | 40.7% |
| 2019 FY | 8.06 Billion CNY | 31.41% |
| 2019 Q1 | 6.04 Billion CNY | -1.47% |
| 2019 Q2 | 6.06 Billion CNY | 0.3% |
| 2019 Q4 | 8.06 Billion CNY | -5.5% |
| 2018 Q2 | 5.94 Billion CNY | 0.0% |
| 2018 Q1 | 5.94 Billion CNY | 107.64% |
| 2018 Q3 | 6.13 Billion CNY | 3.31% |
| 2018 Q4 | 6.13 Billion CNY | 0.0% |
| 2018 FY | 6.13 Billion CNY | 114.52% |
| 2017 Q2 | 3.18 Billion CNY | 0.0% |
| 2017 FY | 2.86 Billion CNY | 76.18% |
| 2017 Q4 | 2.86 Billion CNY | 0.01% |
| 2017 Q3 | 2.86 Billion CNY | -10.19% |
| 2017 Q1 | 3.18 Billion CNY | 96.15% |
| 2016 Q2 | 2.24 Billion CNY | 0.01% |
| 2016 Q3 | 1.62 Billion CNY | -27.55% |
| 2016 Q4 | 1.62 Billion CNY | 0.01% |
| 2016 FY | 1.62 Billion CNY | 223.07% |
| 2016 Q1 | 2.24 Billion CNY | 345.86% |
| 2015 Q4 | 502.71 Million CNY | 0.03% |
| 2015 Q3 | 502.57 Million CNY | -16.73% |
| 2015 Q2 | 603.53 Million CNY | 0.02% |
| 2015 Q1 | 603.39 Million CNY | 97.49% |
| 2015 FY | 502.71 Million CNY | 64.53% |
| 2014 FY | 305.53 Million CNY | -59.01% |
| 2014 Q2 | 1.01 Billion CNY | 0.01% |
| 2014 Q1 | 1.01 Billion CNY | 36.04% |
| 2014 Q3 | 305.39 Million CNY | -69.88% |
| 2014 Q4 | 305.53 Million CNY | 0.05% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 FY | 745.3 Million CNY | 0.0% |
| 2013 Q4 | 745.3 Million CNY | 0.02% |
| 2013 Q3 | 745.16 Million CNY | 0.0% |
| 2012 Q1 | 559.52 Million CNY | 22.75% |
| 2012 Q2 | 589.6 Million CNY | 5.38% |
| 2012 FY | - CNY | -100.0% |
| 2011 Q2 | 335.65 Million CNY | 25.97% |
| 2011 FY | 455.81 Million CNY | 71.71% |
| 2011 Q3 | 507.55 Million CNY | 51.22% |
| 2011 Q4 | 455.81 Million CNY | -10.19% |
| 2011 Q1 | 266.44 Million CNY | 0.37% |
| 2010 Q1 | 247.17 Million CNY | 23.17% |
| 2010 FY | 265.45 Million CNY | 32.27% |
| 2010 Q4 | 265.45 Million CNY | 9.73% |
| 2010 Q3 | 241.91 Million CNY | 0.74% |
| 2010 Q2 | 240.12 Million CNY | -2.85% |
| 2009 FY | 200.68 Million CNY | 42.56% |
| 2009 Q4 | 200.68 Million CNY | 0.0% |
| 2008 FY | 140.77 Million CNY | -44.37% |
| 2007 FY | 253.05 Million CNY | 774.64% |
| 2006 FY | 28.93 Million CNY | 169.39% |
| 2005 FY | 10.74 Million CNY | -81.16% |
| 2004 FY | 57 Million CNY | -54.4% |
| 2003 FY | 125.01 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| CSPC Pharmaceutical Group Limited | 778.3 Million HKD | -982.35% |